Mammalian expression of virus-like particles as a proof of principle for next generation polio vaccines

Journal article

To counteract hand, foot, and mouth disease-causing viruses such as enterovirus A71 and coxsackievirus A6, virus-like particles (VLPs) have emerged as a leading contender for the development of a multivalent vaccine. However, VLPs have shown rapid conversion from a highly immunogenic state to a less immunogenic state and low particle integrity lifetimes compared to inactivated virus vaccines, thus raising concerns about their overall stability. Here, we produce VLPs to investigate capsid stability using cryogenic electron microscopy (cryo-EM), mass spectrometry (MS), biochemical assays, and atomic force microscopy (AFM). In contrast to prior studies and prevailing hypotheses, we show that insect-cell produced enterovirus VLPs include encapsidated RNA fragments with viral protein coding sequences. Our integrated approach reveals that CVA6 VLPs do not undergo viral maturation, in contrast to virions; that they can encapsidate RNA fragments, similarly to virions; and that despite the latter, they are more brittle than virions. Interestingly, this indicates that CVA6 VLP stability is more affected by lack of viral maturation than the presence of RNA. Our study highlights how the development of VLPs as vaccine candidates should encompass probing for unwanted (viral) RNA content and establishing control of their maturation to enhance stability

Authors: Bahar, MW; Porta, C; Fox, H; Macadam, AJ; Fry, EE

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Nature Research
• Journal: npj Vaccines
• Volume: 6
• Issue: 1
• Pages: 5-5
• Article number: 5
• Publication date: 2021-01-08
• DOI: 10.1038/s41541-020-00267-3
• EISSN: 2059-0105
• ISSN: 2059-0105
• Language: English
• Keywords: Poliovirus; Poliomyelitis eradication; Biology; Virus-like particle; Recombinant DNA; Polio Vaccination; Antigen; Microbiology; Virology; Genetics; Vaccination; Virus; Poliomyelitis; Gene